FDA Issues Class II Blood Pressure Medication Recall, Over 13,000 Bottles Affected
The FDA initiated a second recall of its 25 mg chlorthalidone tablets this year, bringing the total to more than 25,000 bottles. Anastasiia Sienotova/Getty Images 13,567 bottles of 25 mg chlorthalidone tablets were recalled after failing lab tests, according to the FDA. It’s the manufacturer’s second recall of the tablets this year, all with the same expiration date. Together, the two Class II…
The Food and Drug Administration (FDA) has announced a second recall of its 25 mg chlorthalidone tablets this year, with over 13,500 bottles affected. Manufactured by Inventia Healthcare Limited, the tablets failed lab tests, specifically the dissolution specifications test which measures the medicine's release from the pill. The Food and Drug Administration (FDA) classified both recalls as Class II, indicating temporary health issues may occur but serious harm is unlikely.
Patients who have taken the recalled medication are advised to contact their pharmacy for further guidance.
Written by urgent.news from Healthline News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
